The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance.
Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. · 2006
Read The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. by Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1332664.txt.
Introduction
Alonso-Magdalena and co-authors showed bisphenol A disrupts insulin control in mice in 2006. Pancreatic beta cells store and release insulin to manage blood sugar. BPA mimics the hormone estradiol in the body. Adult mice got a single low dose of either compound.
A dose of 10 micrograms per kilogram rapidly lowered blood sugar. Plasma insulin rose at the same time. Longer exposure raised beta-cell insulin content within two days. After four days, mice showed chronic high insulin and altered tolerance tests. Alonso-Magdalena links environmental estrogens to insulin resistance and diabetes risk.
Catalog record
| CREATOR | Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC0 1.0 Universal |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance By Paloma Alonso-Magdalena, Sumiko Morimoto, Cristina Ripoll, Esther Fuentes, Angel Nadal Published in: Environmental Health Perspectives DOI: 10.1289/ehp.8451 ABSTRACT The function of the pancreatic β-cell is the storage and release of insulin, the main hormone involved in blood glucose homeostasis. The results in this article show that the widespread environmental contaminant bisphenol-A (BPA) imitates 17β-estradiol (E2) effects in vivo on blood glucose homeostasis through genomic and nongenomic pathways. The exposure of adult mice to a single low dose (10 μg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin. Longer exposures to E2 and BPA induce an increase in pancreatic β-cell insulin content in an estrogen-receptor–dependent manner. This effect is visible after 2 days of treatment and starting at doses as low as 10 μg/kg/day. After 4 days of treatment with either E2 or BPA, these mice developed chronic hyperinsulinemia, and their glucose and insulin tolerance tests were altered. These experiments unveil the link between environmental estrogens and insulin resistance. Therefore, either abnormal levels of endogenous estrogens or environmental estrogen exposure enhances the risk of developing type 2 diabetes mellitus, hypertension, and dyslipidemia. Insulin resistance is a crucial constituent of the metabolic syndrome, and its presence predicts type 2 diabetes and atherosclerotic cardiovascular disease (DeFronzo and Ferrannini 1991). In addition to insulin resistance, type 2 diabetes mellitus is also characterized by a progressive β-cell dysfunction. In most patients, both symptoms are present several years before the onset of hyperglycemia. The incidence of diabetes has increased in the last decades, and at present it is reaching epidemic levels (177 million persons with diabetes in the world; World Health Organization 2005). The cornerstones of its development are related to modern lifestyle, principally, a lack of exercise and an unhealthy diet. Other pathologies whose incidence rose dramatically after World War II, such as cancer, reproductive impairment, and neurodegenerative diseases, are probably related to the increase of endocrine-disrupting chemicals (EDCs) in the environment (Colborn et al. 1996). However, an experimental link between EDCs and diabetes has not yet been established, although a connection at the epidemiologic level in humans has been recently proposed for dioxin, an environmental contaminant that acts through other than estrogen receptors (ERs) as an endocrine disruptor (Bertazzi et al. 2001; Rene and Bunce 2002). A large number of EDCs act by mimicking the action of the sex hormone 17β-estradiol (E2) (Colborn et al. 1993). In most cases they bind to the classic ERs, ER-α and ER-β (McLachlan 2001; Newbold 2004), but they can also act through novel estrogen targets (Nadal et al. 2005). At physiologic levels, E2 is thought to be involved in maintaining normal insulin sensitivity and to be beneficial for β-cell function (Livingstone and Collison 2002; Louet et al. 2004). However, abnormal levels of E2 may promote insulin resistance (Livingstone and Collison 2002), similar to what occurs in normal puberty and pregnancy (Amiel et al. 1991; Hollingsworth 1983). Therefore, the exposure to an exogenous chemical acting as the natural hormone E2, but at an inappropriate concentration and during an improper time window, may enhance the risk of developing insulin resistance. In spite of the many clinical studies that link sex steroids and actions of insulin, few studies have investigated the molecular basis of the interaction between E2, the pancreatic β-cell function, blood glucose homeostasis, and the development of diabetes. Pancreatic β-cells contain both types of ERs, ER-α and ER-β (Nadal et al. 2000). Although their functions are still greatly undetermined, ER-α and ER-β are involved in important aspects of the β-cell physiology (Nadal et al. 2004; Sutter-Dub 2002). These include protection against β-cell death caused by cytokines (Contreras et al. 2002) and, after a prolonged application, a beneficial effect on diabetes in mice expressing human islet amyloid peptide (Geisler et al. 2002). The involvement of ERs in lipid and glucose metabolism has been demonstrated in ER-α knockout mice that display increased adiposity, insulin resistance, and glucose intolerance (Heine et al. 2000). In addition, β-cells have the nonclassical membrane ER (ncmER) that triggers rapid effects (Nadal et al. 1998, 2000; Quesada et al. 2002). Recently, a similar receptor has been found in Drosophila (Srivastava et al. 2005). E2 rapidly potentiates β-cell signaling systems and insulin release via this ncmER, an effect that is mimicked by EDCs, including bisphenol A (BPA) (Nadal et al. 2004). BPA is one of the most common chemicals that behaves as an endocrine disruptor. It was the first synthetic estrogen without a steroid structure (Dodds and Lawson 1936), but because of its properties as a cross-linking chemical, BPA was widely chosen by the chemical industry to produce plastic polymers, mainly poly-carbonates. Nowadays, it is used in the manufacture of barrier coatings for the inner surfaces of food and beverage cans. High concentrations of BPA have been detected in food and water extracted from autoclaved cans (Brotons et al. 1995). BPA is one of the highest-volume chemicals produced in the world, and its exposure is widespread: it has been found in 95% of the urine samples from people in the United States and to a similar extent is found in human blood, as well (Ikezuki et al. 2002; vom Saal and Hughes 2005). The European Commission’s Scientific Committee on Food (ECSCF 2002) reported a tolerable daily intake (TDI) of 10 μg/kg/day. However, the U.S. Environmental Protection Agency (U.S. EPA) considers 50 μg/kg/day the reference dose based on the lowest observed adverse effect level (LOAEL) of 50 mg/kg/day, according to studies performed in the 1980s (vom Saal and Hughes 2005). In vivo studies using much lower doses of BPA than the LOAEL have shown that it affects sexual maturation (Howdeshell et al. 1999), induces a decrease in daily sperm count and fertility (vom Saal et al. 1998), disrupts chromosome alignment (Hunt et al. 2003), and affects synaptogenesis (McLusky et al. 2005). In spite of this evidence, there is an ongoing debate with the chemical industry that is still skeptical about the risk of low doses of BPA (Bisphenol A Global Industry Group 2005). In this article we show that the exposure of adult mice to BPA, at doses about 1,000-fold less than the LOAEL established by the U.S. EPA, alters blood glucose homeostasis in vivo. It rapidly increases plasma insulin, altering blood glucose concentration through a nonclassical estrogen pathway. Longer exposure increases β-cell insulin content, an effect that involves classic ERs. These longer exposures generate chronic hyperinsulinemia in the fed state and peripheral insulin resistance. MATERIALS AND METHODS Materials. We obtained ICI182,780 (ICI) from Tocris Cookson Ltd. (Avonmouth, UK), tocopherol-stripped corn oil from MP Biomedicals, LLC (Solon, OH, USA), and soluble insulin from Humulina Regular (Lilly, Madrid, Spain). Other substances were obtained from Sigma (Madrid, Spain). Animals. We used Swiss albino OF1 male mice (8–10 weeks of age) throughout this study. All animals were kept under standard housing conditions and were treated humanely and with regard for alleviation of suffering. An internal animal care and use committee reviewed and approved the method used. Treatment. Stimuli (E2 and BPA) were dissolved in tocopherol-stripped corn oil and administered subcutaneously at various concentrations. The